276 related articles for article (PubMed ID: 21047921)
41. Acute and short-term effects of growth hormone on insulin-like growth factors and their binding proteins: serum levels and hepatic messenger ribonucleic acid responses in humans.
Olivecrona H; Hilding A; Ekström C; Barle H; Nyberg B; Möller C; Delhanty PJ; Baxter RC; Angelin B; Ekström TJ; Tally M
J Clin Endocrinol Metab; 1999 Feb; 84(2):553-60. PubMed ID: 10022415
[TBL] [Abstract][Full Text] [Related]
42. Diagnostic value of the acid-labile subunit in acromegaly: evaluation in comparison with insulin-like growth factor (IGF) I, and IGF-binding protein-1, -2, and -3.
Arosio M; Garrone S; Bruzzi P; Faglia G; Minuto F; Barreca A
J Clin Endocrinol Metab; 2001 Mar; 86(3):1091-8. PubMed ID: 11238491
[TBL] [Abstract][Full Text] [Related]
43. Nutrition related hormonal changes in obese children.
Yasunaga T; Furukawa S; Katsumata N; Horikawa R; Tanaka T; Tanae A; Hibi I
Endocr J; 1998 Apr; 45(2):221-7. PubMed ID: 9700475
[TBL] [Abstract][Full Text] [Related]
44. Usefulness of different biochemical markers of the insulin-like growth factor (IGF) family in diagnosing growth hormone excess and deficiency in adults.
Marzullo P; Di Somma C; Pratt KL; Khosravi J; Diamandis A; Lombardi G; Colao A; Rosenfeld RG
J Clin Endocrinol Metab; 2001 Jul; 86(7):3001-8. PubMed ID: 11443159
[TBL] [Abstract][Full Text] [Related]
45. [Efficacy and safety of recombinant human growth hormone solution in children with growth hormone deficiency in China: a multicenter trial].
Hou L; Luo XP; Du ML; Ma HM; Gong CX; Li YC; Shen SX; Zhao ZH; Liang L; Dong GP; Yan CY; Du HW
Zhonghua Er Ke Za Zhi; 2009 Jan; 47(1):48-52. PubMed ID: 19573383
[TBL] [Abstract][Full Text] [Related]
46. Effects of short-term caloric restriction on circulating free IGF-I, acid-labile subunit, IGF-binding proteins (IGFBPs)-1-4, and IGFBPs-1-3 protease activity in obese subjects.
Rasmussen MH; Juul A; Kjems LL; Hilsted J
Eur J Endocrinol; 2006 Oct; 155(4):575-81. PubMed ID: 16990657
[TBL] [Abstract][Full Text] [Related]
47. Free and total insulin-like growth factors and insulin-like growth factor binding proteins during 14 days of growth hormone administration in healthy adults.
Skjaerbaek C; Frystyk J; Møller J; Christiansen JS; Orskov H
Eur J Endocrinol; 1996 Dec; 135(6):672-7. PubMed ID: 9025711
[TBL] [Abstract][Full Text] [Related]
48. Circulating IGF binding protein-1 is inversely associated with leptin in non-obese men and obese postmenopausal women.
Söderberg S; Ahrén B; Eliasson M; Dinesen B; Brismar K; Olsson T
Eur J Endocrinol; 2001 Mar; 144(3):283-90. PubMed ID: 11248749
[TBL] [Abstract][Full Text] [Related]
49. Endocrine and metabolic effects of long-term administration of [Nle27]growth hormone-releasing hormone-(1-29)-NH2 in age-advanced men and women.
Khorram O; Laughlin GA; Yen SS
J Clin Endocrinol Metab; 1997 May; 82(5):1472-9. PubMed ID: 9141536
[TBL] [Abstract][Full Text] [Related]
50. Changes in serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 levels during growth hormone treatment in prepubertal short children born small for gestational age.
Boguszewski M; Jansson C; Rosberg S; Albertsson-Wikland K
J Clin Endocrinol Metab; 1996 Nov; 81(11):3902-8. PubMed ID: 8923836
[TBL] [Abstract][Full Text] [Related]
51. Characterization of the IGF system in 15 patients with Alström syndrome.
Maffei P; Boschetti M; Marshall JD; Paisey RB; Beck S; Resmini E; Collin GB; Naggert JK; Milan G; Vettor R; Minuto F; Sicolo N; Barreca A
Clin Endocrinol (Oxf); 2007 Feb; 66(2):269-75. PubMed ID: 17223998
[TBL] [Abstract][Full Text] [Related]
52. Changes in serum IGF-I and IGFBP-3 concentrations during the IGF-I generation test performed prospectively in children with short stature.
Cotterill AM; Camacho-Hübner C; Duquesnoy P; Savage MO
Clin Endocrinol (Oxf); 1998 Jun; 48(6):719-24. PubMed ID: 9713560
[TBL] [Abstract][Full Text] [Related]
53. Confirmation of severe GH deficiency after final height in patients diagnosed as GH deficient during childhood.
Attanasio AF; Howell S; Bates PC; Blum WF; Frewer P; Quigley C; Shalet SM
Clin Endocrinol (Oxf); 2002 Apr; 56(4):503-7. PubMed ID: 11966743
[TBL] [Abstract][Full Text] [Related]
54. Insulin regulation of insulin-like growth factor binding protein-1 in obese and nonobese humans.
Conover CA; Lee PD; Kanaley JA; Clarkson JT; Jensen MD
J Clin Endocrinol Metab; 1992 Jun; 74(6):1355-60. PubMed ID: 1375600
[TBL] [Abstract][Full Text] [Related]
55. Initial characterization of the GH-IGF axis and nutritional status of the Ati Negritos of the Philippines.
Clavano-Harding AB; Ambler GR; Cowell CT; Garnett SP; Al-Toumah B; Coakley JC; Ho KK; Baxter RC
Clin Endocrinol (Oxf); 1999 Dec; 51(6):741-7. PubMed ID: 10619979
[TBL] [Abstract][Full Text] [Related]
56. Long-term effects of continuous subcutaneous infusion versus daily subcutaneous injections of growth hormone (GH) on the insulin-like growth factor system, insulin sensitivity, body composition, and bone and lipoprotein metabolism in GH-deficient adults.
Laursen T; Gravholt CH; Heickendorff L; Drustrup J; Kappelgaard AM; Jørgensen JO; Christiansen JS
J Clin Endocrinol Metab; 2001 Mar; 86(3):1222-8. PubMed ID: 11238512
[TBL] [Abstract][Full Text] [Related]
57. Evaluation of insulin-like growth factor-1 and insulinlike growth factor binding protein-3 in diagnosis of growth hormone deficiency in short-stature children.
Ali A; Hashim R; Khan FA; Sattar A; Ijaz A; Manzoor SM; Younas M
J Ayub Med Coll Abbottabad; 2009; 21(3):40-5. PubMed ID: 20929010
[TBL] [Abstract][Full Text] [Related]
58. Growth in children with craniopharyngioma following surgery.
Tiulpakov AN; Mazerkina NA; Brook CG; Hindmarsh PC; Peterkova VA; Gorelyshev SK
Clin Endocrinol (Oxf); 1998 Dec; 49(6):733-8. PubMed ID: 10209560
[TBL] [Abstract][Full Text] [Related]
59. Unequal impact of short-term testosterone repletion on the somatotropic axis of young and older men.
Gentili A; Mulligan T; Godschalk M; Clore J; Patrie J; Iranmanesh A; Veldhuis JD
J Clin Endocrinol Metab; 2002 Feb; 87(2):825-34. PubMed ID: 11836328
[TBL] [Abstract][Full Text] [Related]
60. Five-day pulsatile gonadotropin-releasing hormone administration unveils combined hypothalamic-pituitary-gonadal defects underlying profound hypoandrogenism in men with prolonged critical illness.
van den Berghe G; Weekers F; Baxter RC; Wouters P; Iranmanesh A; Bouillon R; Veldhuis JD
J Clin Endocrinol Metab; 2001 Jul; 86(7):3217-26. PubMed ID: 11443192
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
